
Research
Norlowe Research works in two areas, healthcare and quantitative research.
Healthcare
Most of the firm’s healthcare questions concern patients in everyday practice, where treatment is less controlled than in a trial and fair comparisons are harder to make. Much depends on knowing who is counted and how each measure is defined.


Chronic disease
How many adults have a long-term condition such as diabetes, how far the count depends on the definition used, and how it varies from one county to the next.
Data: National Health and Nutrition Examination Survey, PLACES local health estimates
Pharmacoepidemiology
How a medicine is used once it is approved, and what emerges when far more patients take it than any trial enrolled. Some effects are too rare or too delayed to appear any sooner.
Data: Medicare Part D Prescribers, FDA Adverse Event Reporting System
Trial evidence
The design and reporting of clinical trials, and the way the case for a treatment changes as further trials finish.
Data: ClinicalTrials.gov
Cost and coverage of care
Patterns in the use of health services and in what they cost, including how spending moves when coverage or prices change.
Data: Medical Expenditure Panel Survey
Quality measurement
How the measures used to compare hospitals are constructed, and how much of the difference they show between hospitals reflects the care given rather than differences in patients or chance.
Data: Hospital quality measures
Medicines in health data
How a medicine is named and coded on its label and in health data standards, and what is lost when one coding is translated into another.
Data: RxNorm, DailyMed
Quantitative research
Health data are usually collected to deliver care, to pay for it, or to meet a reporting rule, rather than to answer research questions. The quality of an estimate rests as much on how those data are cleaned and linked as on the model fitted to them.


Research design
How a question is turned into a comparison that existing data can answer. Who is eligible and when follow-up begins often matter more than the choice of model.
Case definitions
Which records identify a condition or an outcome, and how much an estimate changes when the definition does.
Data quality and linkage
Whether records from separate sources describe the same medicine or hospital, and how gaps in the data, such as counts withheld for privacy, can distort a total.
Statistical analysis
How a model is matched to the question and the data, and how the uncertainty in each estimate is carried into the conclusion. A ranking of hospitals, for example, can look more certain than the data behind it.
Data
The firm’s research draws on data released by United States government agencies. It has worked with the sources below.
| Source | Kept by | What it holds | Used for |
|---|---|---|---|
| Medicare Part D Prescribers | Centers for Medicare & Medicaid Services | Yearly totals of the prescriptions filled under Medicare Part D, listed by prescriber and by drug. Rows based on fewer than eleven claims are withheld. | Pharmacoepidemiology |
| Hospital quality measures | Centers for Medicare & Medicaid Services | Measures reported for each hospital, among them death and readmission rates, safety events, and patients’ accounts of their stay. | Quality measurement |
| National Health and Nutrition Examination Survey | National Center for Health Statistics | A national survey that pairs household interviews with physical examinations and laboratory tests. | Chronic disease |
| Medical Expenditure Panel Survey | Agency for Healthcare Research and Quality | A national survey of households on the health services they use, what those services cost, and how they are paid for. | Cost and coverage of care |
| FDA Adverse Event Reporting System | Food and Drug Administration | Reports of suspected adverse events and medication errors, sent in by clinicians, patients, and manufacturers. | Pharmacoepidemiology |
| ClinicalTrials.gov | National Library of Medicine | A registry of clinical trials, with the summary results that have been posted for completed trials. | Trial evidence |
| PLACES local health estimates | Centers for Disease Control and Prevention | Modeled estimates of health measures for counties, cities and towns, census tracts, and ZIP Code Tabulation Areas. | Chronic disease |
| RxNorm and DailyMed | National Library of Medicine | RxNorm gives each clinical drug a standard name and identifier. DailyMed holds the labels that manufacturers file with the Food and Drug Administration. | Medicines in health data |
None of these sources identifies an individual patient. Each is used under the terms its agency sets.
Observational evidence
Many questions about treatment and care cannot be settled by a controlled experiment and have to be answered from observational evidence. Methods are chosen with that limitation in mind, and the assumptions behind each conclusion are stated. The firm also reports how far a conclusion moves when reasonable analytic choices are made differently.
Health data are shaped by the rules under which they are recorded, and those rules change. Definitions and measurements drift, and an effect that looks clear in one period or population can shrink or vanish in the next.
Many errors in health research come down to timing. In immortal time bias, one of the most common, patients are counted as treated from the start of follow-up because of a prescription filled later. They must survive until that prescription to be counted, so the treated group is credited with time in which it could not die.
Immortal time bias in research on medicines
Counted as treated from the start
- Follow-up begins
- First prescription